Cardio Diagnostics Holdings, Inc. (CDIO)
1.86
+0.03
(+1.64%)
USD |
NASDAQ |
Sep 04, 16:00
1.83
-0.03
(-1.61%)
After-Hours: 20:00
Cardio Diagnostics Holdings SG&A Expense (TTM) : 3.501M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.501M |
| March 31, 2026 | 2.224M |
| December 31, 2025 | 2.156M |
| September 30, 2025 | 3.344M |
| June 30, 2025 | 4.557M |
| March 31, 2025 | 5.777M |
| December 31, 2024 | 8.352M |
| September 30, 2024 | 8.377M |
| June 30, 2024 | 8.348M |
| March 31, 2024 | 9.576M |
| December 31, 2023 | 7.030M |
| Date | Value |
|---|---|
| September 30, 2023 | 9.246M |
| June 30, 2023 | 8.997M |
| March 31, 2023 | 7.242M |
| December 31, 2022 | 5.858M |
| September 30, 2022 | 2.126M |
| June 30, 2022 | 0.999M |
| March 31, 2022 | 0.2483M |
| December 31, 2021 | 0.0209M |
| September 30, 2021 | 0.0007M |
| June 30, 2021 | 0.0004M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tenax Therapeutics, Inc. | 23.36M |
| Exicure, Inc. | 5.28M |
| Century Therapeutics, Inc. | 20.16M |
| Absci Corp. | 35.28M |
| Celularity, Inc. | 51.27M |